Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b

By Nagamine Takeaki   Takagi Hitoshi   Takayama Hisashi   Kojima Akira   Kakizaki Satoru   Mori Masatomo   Nakajima Katuyuki  

Biological Trace Element Research, Vol. 75, Iss. 1-3, 2000-06 ,pp. : 53-63

Humana Press, Inc

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Interferon in the treatment of chronic hepatitis C: a drug caught between past and future

By Vezali Elena   Aghemo Alessio   Colombo Massimo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 301-313

Informa Healthcare

Access to resources Recommend Favorite

Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B

By Özbal Ebru   Helvaci Mehmet   Kasirga Erhun   Akdenizoglu Figen   Kizilgüneşler Asli  

Biological Trace Element Research, Vol. 90, Iss. 1-3, 2002-12 ,pp. : 31-38

Humana Press, Inc

Access to resources Recommend Favorite

Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C

By Scagnolari Carolina   Antonelli Guido  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 693-711

Informa Healthcare

Access to resources Recommend Favorite